The Stemness Phenotype Model

Table 2

Detection of CSCs in established lung cancer cell lines.

Cell line	Percentage	Method	Reference
LHK2, 1-87, A549, Lc817	0.4% to 2.8%	SP	[23]
A549	0.98%	CD133	[24]
H446	1%	CD133	[24]
A549	>45%	Cloning and tumorigenic analyses	[25]
H446	>45%	Cloning and tumorigenic analyses	[25]
A549	24%	SP	[26]
H460, H23, HTB-58, A549, H441, and H2170	1.5% to 6.1%	SP	[27]
NCI-H82, H146, H526, A549, and H460	0.8% to 1%	SP	[28]
H446	6.3±0.1	SP	[29]
NSCLC cell lines H460, H125, H322, H358	average of 2% (2.16±1.28)	Aldefluor followed by clonogenic assays	[30]
A549, H1299, CCL-1, CCL-5, C299	0.3% to 1%	CD133^+ follow serum free culture	[31]
60 primary tissue samples	0.02% to a maximum of 35%	CD133^+ESA^+	[32]